Cyanoaminoquinolones and tetrazoloaminoquinolones as GSK-3 inhibitors

Details for Australian Patent Application No. 2008299903 (hide)

Owner Kyorin Pharmaceutical Co., Ltd Activx Biosciences, Inc.

Inventors Szardenings, Katrin; Li, Bei

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2008299903

PCT Pub. Number WO2009/035634

Priority 60/993,346 11.09.07 US

Filing date 11 September 2008

Wipo publication date 19 March 2009

International Classifications

C07D 498/06 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms

A61K 31/4741 (2006.01)

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

Event Publications

8 April 2010 PCT application entered the National Phase

  PCT publication WO2009/035634 Priority application(s): WO2009/035634

6 January 2011 Assignment before Grant

  Activx Biosciences, Inc.; Kyorin Pharmaceutical Co., Ltd The application has been assigned to Kyorin Pharmaceutical Co., Ltd

20 January 2011 Amendment Made

  The nature of the amendment is: Amend co-inventor; Szardenings, Katrin to Szardenings, Anna Katrin

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008299913-Attenuated Mycoplasma gallisepticum strains

2008299896-Tartrate salts or complexes of quinazoline based EGFR inhibitors containing a zinc binding moiety